Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 26, 1998

View Archived Issues

YM-175 treatment reduces alveolar bone loss in dogs with periodontitis

Incyte to acquire Hexagen and its technology for detecting SNPs

International team identifies compounds for treating slow-growing tumors

Life Medical Sciences: Q2 1998 highlights

GelTex: Q2 1998 highlights

Aphton patents its vaccine-like technology based on the neutralization of gastrin

Rebetron receives priority review status

Antidiabetes drug from Amylin enters phase I clinical study

Incert appears to prevent the formation of postoperative adhesions

Pagoclone reduces frequency of panic attacks in patients with panic disorder

TAN-2421-A1: a novel xanthine derivative with immunomodulating activity

British Biotech claims MMP inhibitors for blocking connective tissue degradation

Dual 5-HT reuptake inhibitors/5-HT1A antagonists with potential as antidepressants

Neuroprotective glutamate receptor antagonists disclosed by Warner-Lambert

Pfizer discovers new treatments for atherosclerosis and related disorders

Allelix research into antimigraine compounds proves fruitful

ACS news flash: Rhone-Poulenc Rorer studies dual PDE4/MMP inhibitors

Parke-Davis synthesizes potent and selective D4 ligands with antipsychotic potential

News from ACS: PD-180988 is a potent and selective ETA antagonist

Selective MMP-3 inhibitor PS-508 described at ACS meeting

SSRI produces significant improvements in patients with social phobia

Agouron's HIV protease inhibitor approved for marketing in Canada

Bio-Technology General in-licenses PEG-uricase for development

IMpact-RSV trial results announced at international congress

Advisory committee recommends European approval for Viagra

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...